Physician

Mohamad Hassan Fakhreddine, M.D.

According to 2025 Medicare claims, Mohamad Fakhreddine, M.D. (NPI: 1790128783) practices radiation oncology in the Kalamazoo-Portage, MI market, with the plurality of this provider's patient population coming from Kalamazoo, MI. This provider's primary affiliated billing organization is WEST MICHIGAN CANCER CENTER (NPI: 1588778484; TIN: 383061574) and primary practice location at 49007-3731.

Fakhreddine's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 132 traditional Medicare patients, billed 1,822 HCPCS/CPT codes, and received $325,195 in Medicare payments. The top billing code was G6015 (Intensity modulated treatment delivery, single or multiple fields/arcs,via narrow spatially and temporally modulated beams, binary, dynamic mlc, per treatment session). Part D data shows 211 prescription claims across 76 beneficiaries totaling $3,514 in drug costs, led by Dexamethasone (Dexamethasone). 2022 DME data shows 12 claims. Open Payments data shows 1 records totaling $24. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have risen steadily, from $300 to $3,514. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	48	910	$130,866
2019	114	3,423	$367,692
2020	116	4,246	$381,203
2021	206	5,029	$627,466
2022	155	2,071	$297,586
2023	138	1,783	$297,015
2024	132	1,822	$325,195

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	N/R	N/R	N/R
2016	N/R	12	$300
2017	N/R	N/R	N/R
2018	N/R	18	$807
2019	44	122	$3,095
2020	42	114	$2,576
2021	47	145	$4,274
2022	31	107	$3,828
2023	63	206	$6,767
2024	76	211	$3,514

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	11	$147
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	12	$260
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
G6015	Intensity modulated treatment delivery, single or multiple fields/arcs,via narrow spatially and temporally modulated beams, binary, dynamic mlc, per treatment session	55	339	$272
77334	Design and construction of complex radiation treatment device	41	101	$98
77014	Ct guidance for insertion of radiation therapy fields	69	435	$94
77336	Continuing radiation therapy consultation per week	45	111	$68
77300	Calculation of radiation therapy dose	42	143	$51

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Dexamethasone	Dexamethasone	27	477	$436
Pentoxifylline	Pentoxifylline	13	600	$402
Lidocaine Hcl Viscous	Lidocaine Hcl	21	122	$371
Ssd	Silver Sulfadiazine	17	589	$286
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	19	171	$194

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	1	$24	Novartis Pharmaceuticals Corporation
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Mohamad Hassan Fakhreddine, M.D.?

Tedicare shows public-source Medicare data for Mohamad Hassan Fakhreddine, M.D. (NPI 1790128783), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Mohamad Hassan Fakhreddine, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Mohamad Hassan Fakhreddine, M.D.?

Mohamad Hassan Fakhreddine, M.D. is linked to WEST MICHIGAN CANCER CENTER (billing NPI 1588778484) in the available physician profile data.

Does Mohamad Hassan Fakhreddine, M.D. have Open Payments data?

Mohamad Hassan Fakhreddine, M.D. has 1 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.